Dallas L Williams

Suggest Changes
Learn More
PURPOSE Currently, treatment recommendations for small-cell urothelial cancer (SCUC) are based on anecdotal case reports and small retrospective series. We now report results from the first phase II(More)
BACKGROUND Neoadjuvant chemotherapy improves the survival of patients with high-risk urothelial cancer. However, the lack of curative alternatives to cisplatin-based chemotherapy is limiting for(More)
PURPOSE We investigated the feasibility, safety, and antitumor activity of weekly gemcitabine given in combination with low doses of cisplatin and ifosfamide in previously treated patients with(More)
4561 Background: Several chemotherapy regimens provide palliative benefit in AIPC. With the goal of efficiently selecting promising regimens for more advanced trials, we applied a novel trial design(More)
5071 Background: We developed a clinical trial incorporating response into the treatment algorithm. Patients meeting a certain threshold of response continued with the same treatment; those with(More)
BACKGROUND The objectives of the current study were to determine the maximum tolerated dose and to evaluate the efficacy of gemcitabine given in combination with strontium-89 to patients with(More)